Dr. Yang,Pan-Chyr
Humanized COVID‐19 decoy antibody effectively blocks viral entry and prevents SARS‐CoV‐2 infection
EMBO Molecular Medicine Nov 30, 2020
MORE
Cancer
Cancer
- Mechanisms of cell cycle checkpoints, nuclear receptors, post-translational modifications, and stemness factors in controlling growth and differentiation of cancer cells
- Molecular mechanisms of signaling circuitries involved in cancer formation, progression and metastasis
- Biomarkers for cancer treatment and prognosis
- Antibody therapies, new anticancer agents, and mechanisms of established anticancer drugs
-
Roffler, Steve R. ( 羅傅倫 )
Distinguished Research Fellow
Division Coordinator
-
Jou, Yuh-Shan ( 周玉山 )
Distinguished Research Fellow
-
Lee, Te-Chang ( 李德章 )
Distinguished Research Fellow
-
Chau, Lee-Young ( 趙麗洋 )
Research Fellow
-
Lin, Wen-chang ( 林文昌 )
Research Fellow
-
Shieh, Sheau-Yann ( 謝小燕 )
Research Fellow
-
Shih, Hsiu-Ming ( 施修明 )
Research Fellow
-
Chen, Shih-Yu ( 陳世淯 )
Assistant Research Fellow
-
Li, Chia-Wei ( 李家偉 )
Assistant Research Fellow
-
Wang, Shu-Ping ( 王書品 )
Assistant Research Fellow
-
Suzuki, Jun ( 鈴木淳 )
Joint Appointment Research Fellow
-
Li, Fu-An ( 李福安 )
Assistant Research Scientist
-
Yang, Pan-Chyr ( 楊泮池 )
Joint Appointment Research Fellow
Academician, Academia Sinica
Joint -
Wu, Cheng-Wen ( 吳成文 )
Corresponding Research Fellow
Academician, Academia Sinica
Corresponding -
Tang, Tang K. ( 唐堂 )
Distinguished Research Fellow
Cross Div.
Cancer Research Highlight
Dr. Lee,Te-Chang
SAHA Overcomes 5-FU Resistance in IFIT2-Depleted Oral Squamous Cell Carcinoma Cells
Cancers Nov 26, 2020
MORE
Dr. Yang,Pan-Chyr
Dr. Wang, Shu-Ping
Antimetabolite pemetrexed primes a favorable tumor microenvironment for immune checkpoint blockade therapy
Journal for ImmunoTherapy of Cancer Nov 26, 2020
MORE
